GlassScriptPhysician profile
Alexander A Hindenburg
NPI 1285684175
$509.06
in general payments reported to CMS, 2019-2025
13 companies · $47.10 in 2025
The $47.10 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.11 · 2021: $28.74 · 2022: $258 · 2023: $81.67 · 2024: $70.78 · 2025: $47.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $143.89 | 2020-2024 | |
| Lilly USA, LLC | $94.68 | 2022 | |
| Celgene Corporation | $48.37 | 2022 | |
| Abbvie INC. | $47.88 | 2022-2025 | |
| Astellas Pharma US INC | $31.34 | 2025 | Cresemba |
| Cti Biopharma Corp. | $24.30 | 2023 | Vonjo |
| Janssen Biotech, INC. | $23.53 | 2022 | |
| Mirati Therapeutics, INC. | $23.06 | 2024 | Krazati |
| Daiichi Sankyo INC. | $21.30 | 2023 | Enhertu |
| Seagen INC. | $20.73 | 2023 | Padcev |
| Merck Sharp & Dohme LLC | $18.06 | 2022 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Hindenburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.